Back to Journals » Stem Cells and Cloning: Advances and Applications » Volume 1

Stem cells and the origin of gliomas: A historical reappraisal with molecular advancements

Authors Levy ML, Ho AL, Hughes S, Menon J, Jandial R

Published 20 January 2009 Volume 2008:1 Pages 41—47

DOI https://doi.org/10.2147/SCCAA.S3851

Michael L Levy1, Allen L Ho1,2, Samuel Hughes3, Jayant Menon1, Rahul Jandial4

1Division of Neurosurgery, University of California, San Diego, La Jolla, California, USA; 2Del E Webb Neurosciences, Aging and Stem Cell Research Center, The Burnham Institute for Medical Research, La Jolla, California, USA; 3Department of Neurological Surgery, Oregon Health and Science University, Portland, OR, USA; 4Division of Neurosurgery, Department of Surgery, City of Hope Cancer Center, Duarte, CA, USA

Abstract: The biology of both normal and tumor development clearly possesses overlapping and parallel features. Oncogenes and tumor suppressors are relevant not only in tumor biology, but also in physiological developmental regulators of growth and differentiation. Conversely, genes identified as regulators of developmental biology are relevant to tumor biology. This is particularly relevant in the context of brain tumors, where recent evidence is mounting that the origin of brain tumors, specifically gliomas, may represent dysfunctional developmental neurobiology. Neural stem cells are increasingly being investigated as the cell type that originally undergoes malignant transformation – the cell of origin – and the evidence for this is discussed.

Keywords: stem cells, gliomas, neural stem cells, brain tumors, cancer stem cells

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Stem cell horizons in intervertebral disc degeneration

Joseph Ciacci, Allen Ho, Christopher P Ames, Rahul Jandial

Stem Cells and Cloning: Advances and Applications 2008, 1:31-39

Published Date: 20 January 2009

Readers of this article also read:

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR

Vascular Health and Risk Management 2014, 10:237-246

Published Date: 25 April 2014

Autoantibody profiling in systemic lupus erythematosus

Hsieh SC, Yu CL

Current Biomarker Findings 2013, 3:55-65

Published Date: 23 August 2013

Household bed net ownership and use among under-5 children in Nigeria

Osuorah DC, Ezeudu CE, Onah SK, Anyabolu OT

Research and Reports in Tropical Medicine 2013, 4:15-27

Published Date: 25 July 2013

Autologous bone marrow cell therapy for peripheral arterial disease

Botti C, Maione C, Coppola A, Sica V, Cobellis G

Stem Cells and Cloning: Advances and Applications 2012, 5:5-14

Published Date: 6 September 2012

Optimal management of equine keratomycosis

Galera PD, Brooks DE

Veterinary Medicine: Research and Reports 2012, 3:7-17

Published Date: 15 March 2012

Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae

Darci R Smith, Monica Ogg, Aura Garrison, et al

Virus Adaptation and Treatment 2010, 2:9-20

Published Date: 26 February 2010

Stem cell horizons in intervertebral disc degeneration

Joseph Ciacci, Allen Ho, Christopher P Ames, Rahul Jandial

Stem Cells and Cloning: Advances and Applications 2008, 1:31-39

Published Date: 20 January 2009

Legal intervention against medical accidents in Japan

Hideo Yasunaga

Risk Management and Healthcare Policy 2008, 1:39-42

Published Date: 16 December 2008